Can SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) cause long-lasting pharyngitis in an 18-year-old patient with a 5-year history of chronic sore throat and no clear diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SARS-CoV-2 Cannot Explain a 5-Year History of Chronic Pharyngitis

SARS-CoV-2 did not exist until late 2019 and therefore cannot be the cause of pharyngitis that began 5 years ago in this 18-year-old patient. 1, 2 The timeline is biologically impossible—this patient's symptoms predate the emergence of the virus by approximately 2-3 years.

Critical Timeline Analysis

  • SARS-CoV-2 emerged in Wuhan, China in late 2019, with the first cases identified at the end of that year 2
  • The WHO declared COVID-19 a public health emergency on January 30,2020 2
  • A 5-year history of sore throat in an 18-year-old means symptoms began around age 13, which would be approximately 2017-2018—well before SARS-CoV-2 existed 1, 2

What About "Long COVID" Pharyngitis?

While COVID-19 can cause acute pharyngitis with an incidence of 5-17.4% during active infection 3, there is no evidence in the provided literature supporting chronic pharyngitis as a manifestation of post-COVID syndrome or "long COVID." The acute pharyngitis associated with SARS-CoV-2 is a symptom of active infection, not a chronic inflammatory condition 3.

Alternative Diagnostic Considerations for This Patient

This patient requires a systematic re-evaluation for other causes of chronic pharyngitis:

Bacterial Causes to Exclude

  • Group C and G streptococci can cause severe or recurrent pharyngitis, though evidence is limited 4
  • Group C streptococci have been associated with exudative tonsillitis and anterior cervical adenopathy in case-control studies 4
  • Mycoplasma pneumoniae and Chlamydophila pneumoniae have been linked to recurrent respiratory symptoms in observational studies, though evidence is limited to specific outbreak settings 4

Non-Infectious Causes to Consider

  • Chronic irritant exposure (smoking, environmental pollutants, occupational exposures)
  • Gastroesophageal reflux disease (GERD) causing chronic posterior pharyngeal inflammation
  • Allergic rhinitis with postnasal drip
  • Chronic sinusitis
  • Autoimmune conditions affecting the pharynx

Structural/Anatomical Issues

  • Chronic tonsillar hypertrophy
  • Peritonsillar pathology
  • Anatomical variants causing chronic irritation

Recommended Diagnostic Workup

Obtain throat culture specifically requesting testing for:

  • Group A, C, and G streptococci 4
  • Consider serologic testing for Mycoplasma pneumoniae and Chlamydophila pneumoniae if recurrent symptoms suggest atypical bacterial infection 4

Additional investigations:

  • Complete blood count with differential to assess for chronic infection or inflammatory process 5
  • Consider referral to otolaryngology for direct laryngoscopy to evaluate for structural abnormalities or chronic inflammatory changes
  • Trial of proton pump inhibitor therapy if GERD is suspected
  • Allergy testing if allergic etiology is suspected

Management Approach

Do not prescribe antibiotics empirically without microbiological confirmation 6, 5

  • The duration of symptoms (5 years) argues strongly against an acute bacterial infection requiring immediate antibiotic therapy
  • Empiric antibiotic use without diagnosis leads to inappropriate treatment and promotes resistance 6

Symptomatic management while pursuing diagnosis:

  • Analgesics such as ibuprofen or acetaminophen for symptom relief 6
  • Avoid aspirin in this age group due to Reye syndrome risk 5

Common Pitfall to Avoid

Do not attribute every respiratory symptom to COVID-19 in the current pandemic era. 3 While co-occurrence of COVID-19 and bacterial pharyngitis has been reported, the temporal relationship in this case makes SARS-CoV-2 an impossible explanation for the chronic symptoms 3. The case report of GAS and COVID-19 co-occurrence emphasizes the importance of not having "singular focus on COVID-19" and missing other treatable causes of pharyngitis 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differentiating Viral and Bacterial Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Pharyngitis After Negative Strep Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the possible diagnosis and next steps for a 45-year-old female patient presenting with a 3-day history of sore throat, initially mild but worsening to severe throat pain, accompanied by transient headache, mild hoarseness, odynophagia, and an erythematous oropharynx without tonsillar swelling or exudates?
What is the recommended treatment for acute viral pharyngitis?
What is the best course of action for an elderly patient presenting with a sore throat, productive cough, nausea, shortness of breath (SOB), sweating, and lethargy, without fever, and with negative tests for influenza (flu), COVID-19, respiratory syncytial virus (RSV), and streptococcal (strep) infection, over the past 5 days?
What is the treatment for a sore throat with hyperpyrexia?
What is the treatment for acute pharyngitis?
What is the recommended treatment for a patient with bacterial conjunctivitis using moxifloxacin (fluoroquinolone antibiotic)?
What are the classic areas of metastasis for neuroendocrine tumors?
When are the most important times to order Thyroid-Stimulating Hormone (TSH) and free Thyroxine (T4) tests in patients with suspected or known thyroid dysfunction?
Can a patient with anuria and hyperkalemia be treated with Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Antagonists (ARBs)?
What is the recommended dose of apixaban (Apixaban) for a patient with a history of pulmonary embolism (PE) that occurred many years ago, for the prevention of recurrent venous thromboembolism (VTE)?
What antibiotics are recommended for patients with sepsis of unknown origin, considering potential impaired renal function and allergies to penicillin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.